Tag Archives: obesity drugs
New weight loss pill promises to fight high blood pressure, diabetes
by JEAN ENERSEN / KING 5 News Posted on May 19, 2010 at 5:45 PM Excessive weight gain isn’t only unhealthy, it’s expensive. Nearly 10 percent of U.S. healthcare dollars are spent on obesity-related expenses. That’s why there’s so much … Continue reading
Motley Fool lists VIVUS as 1 of 5 Stocks Breaking Out
Excerpt from Motley Fool Article VIVUS has a lot riding on its obesity drug Qnexa, which has potentially huge profit potential due to the size (sorry) of its target market. Along with competitor Arena Pharmaceuticals (Nasdaq: ARNA) — who is … Continue reading
Assessing the Chances for the Next Wave of Obesity Drugs
By ANDREW POLLACK New York Times Published: October 16, 2009 How do the three new obesity drugs stack up? So far, investors — and some doctors — are most excited about Vivus’s drug, Qnexa. Patients taking the high dose of … Continue reading
No Clear Winner as Top Obesity Candidates Reveal Detailed Data
By Jennifer Boggs Investors – and prospective partners – hoping that detailed data emerging from this year’s Obesity Society meeting in Washington might shed more light on the three frontrunners in the weight loss drug race came away with some … Continue reading
What is Qnexa? Diet Pill
Qnexa™ is a therapeutic formula and dosing regimen which combines the active ingredients from two previously approved products which demonstrated weight loss properties: phentermine and topiramate. Qnexa simultaneously addresses appetite and satiety, the two main mechanisms that impact eating behavior … Continue reading